Browse 66 market data tables and 55 figures spread through 183 pages and in-depth TOC on “Transplant Diagnostics Market

http://www.marketsandmarkets.com/Market-Reports/global-transplant-diagnostics-market-2531061.html
Early buyers will receive 10% customization on reports.

This report studies the transplant diagnostics market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.36 Billion by 2021, growing at a CAGR of 7.0% during 2016 to 2021.

On the basis of technology, the transplant diagnostics market is segmented into non-molecular assays and molecular assays. The molecular assay technologies segment is further divided into PCR based and sequencing based. This segment is projected to grow at the highest CAGR during the forecast period. This can be attributed to factors such as development and commercialization of innovative PCR instruments and reagents, increasing private funding to develop innovative PCR and NGS-based transplant diagnostic products, growing usage of NGS systems among researchers and diagnostic laboratories, and increasing product offerings in the field of NGS-based transplant diagnostics.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=2531061

North America is expected to be the largest regional segment in the global transplant diagnostics market in 2016, followed by Europe. However, the Asia-Pacific market is expected to be the fastest-growing region during forecast period. A number of factors including increase in adoption rate of PCR & NGS based transplant diagnostic products and improving healthcare infrastructure across major Asian countries are stimulating the growth of the transplant diagnostics market in the Asia-Pacific region.

As of 2015, the global transplant diagnostics market was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (U.S.), bioMérieux S.A. (France), Becton Dickinson and Company (U.S.), CareDx (U.S.), Illumina, Inc. (U.S.), and GenDx (Netherlands), among others.